Agrawal SS, Gullaiya S, Dubey V, Singh V, Kumar A, Nagar A, Tiwari P. 2012. Neurodegenerative shielding by curcumin and its derivatives on brain lesions induced by 6-OHAD model of Parkinson̕ s disease in albino wistar rats. Cardiovasc Psychiotry Neurol, (Article in Press).
Araujo CAC, Leon LL. 2001. Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz, 96: 723-728.
Baenninger R. 1997. On yawning and its functions. Psychon Bull Rev, 4: 198-207.
Baenninger R, Greco M. 1991. Some antecedents and consequences of yawning. Psychol Rec, 41: 435-460.
Baggio G, Ferrari F. 1983. The role of dopaminergic receptors in the behavioral effects of lisuride in male rats. Psychopharmacol, 80: 38-42.
Bhutani MK, Bishoni M, Kulkarni SK. 2009. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chrovic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav, 92: 39-43.
Bishoni M, Chopra K, Kulkarni SK. 2008. Protective effect of curcumin, the active principle of turmeric (Curcuma longa) in haloperidole-induced orofacial dyskinesia and associated behavioral, biochemical and neurochemical changes in rat brain. Pharmacol Biochem Behav, 88: 511-522.
Buadonpri W, Wichitnithad W, Rojsitthisak P, Towiwat P. 2009. Synthetic curcumin inhibits carrageenan-induced paw edema in arts. J health Res, 23: 11-16.
Collins GT, Eguibar JR. 2010. Neuropharmacology of yawning. Front Neurol Neurosci, 28: 90-106.
Collins GT, Newman AH, Grundt P, Rice KC, Husbands SM, Chauvignac C, Chen J, Wang S, Woods JH. 2007. Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacol (Berlin), 193: 159-170.
Collins GT, Witkin GM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH. 2005. Dopamine-agonist induced yawning in rats: a dopamine D3 receptor-mediated behavior. J Pharmacol Exp Ther, 314: 310-319.
Du XX, Xu MH, Jiang H, Song N, Wang J, Xie JX. 2012. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson̕ s disease. Neurosci Bull, 28: 253-258.
Hamaguchi T, Ono K, Yamada M. 2010. Review: curcumin and Alzheimer̕ s disease. CNS Neurosci Ther, 16: 285-297.
Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. 2008. Curcumin: from ancient medicine to current clinical trails. Cell Mol Life Sci, 65: 1631-1652.
KingMd, McCracken DJ, Wade FM, Meiler SE, Alleyne CH Jr, Dhanadapani KM. 2011. Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice. J Neurosurg, 115: 116-123.
Kulkarni SK, Bhutani MK, Bishoni M. 2008. Antidepressant activity of curcumin: involvement of serotonin and dopamine. Psychopharmacol (Berlin), 201: 435-442.
Kumar TP, Antony S, gireesh G, george N, Paulose CS. 2010. Curcumin mosulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of stereptozotocin-induced diabetic rats. J Biomed Sci, 17: 43.
Li SM, Collins GT, Paul NM, Grundt P, Newman AH, Xu M, Grandy DK, Woods JH, Katz JL. 2010. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats. Behav Pharmacol, 21: 171-181.
Melis MR, Argiolas A, Gessa GL. 1987. Apomorphine-induced penile erection and yawning: site of action in brain. Brain Res, 415: 98-108.
Mythri RB, Bharath MM. 2012. Curcumin: a potential neuroprotective agent in Parkinson̕ s disease. Curr Pharm Des, 18: 91-99.
Sharma RA, Gescher AJ, Steward WP. 2005. Curcumin: the story so far. Eur J Cancer, 41: 1955-1968.
Sharma RA, Steward WP, Gescher AJ. 2007. Pharmacokinetic and pharmacodynamics of curcumin. Adv Exp Med Biol, 595: 453-470.
Sokoloff P, Andrieux M, Besancon R, Pilon C, Matres MP, Giros B, Schwartz JC. 1992. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol, 225: 331-337.
Tamaddonfard E, Soraya H, Hamzeh-Gooshchi N. 2008a. Central interaction between physostigmine and histamine during yawning in rats. Pharmacol Rep, 60: 896-903.
Tamaddonfard E, Tajik H, Hamzeh-Gooshchi N. 2008b. Effects of curcumin and vitamin C on visceral nociception induced by acetic acid in rats. Medycyna Wet, 64: 883-885.
Tamaddonfard E, Tajik H, Hamzeh-Gooshci N. 2009. Effects of curcumin, morphine and naloxone on the experimentally-induced paw edema in rats. Int J Vet Res, 3: 25-30.
Tamaddonfard E, Hamzeh-Gooshchi F, Hamzeh-Gooshchi N. 2010. Effect of curcumin on morphine-induced antinociception in acute coeneal pain in rats. Int J Vet Res, 4: 127-131.
Tamaddonfard E, Erfanparast A, Hamzeh-Gooshchi N, Yosofizadeh S. 2012. Effect of curcumin, the active substance of turmeric, on penicillin-induced epileptiform activity in rats. Avicenna J Phytomedicine, 2: 196-205.
Ushijima I, Mizzuki Y, Yamada M. 1988. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats. Psychopharmacology (Berlin), 95: 29-33.
Wang R, Xu Y, Wu HL, Li YB, Li YH, Guo JB, Li XJ. 2008. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur J Pharmacol, 578: 43-50.
Yang S, Ahang D, Yang Z, Xu X, Qian S, Liu L, Wilson B, Block M, hong JS. 2008. Curcumin protects dopaminergic neuron against LPS-induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res, 33: 2044-2053.
Zarrindast MR, Jamshidzadeh A. 1992. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopaminergic D2 receptor activation in rats. Br J Pharmacol, 105: 675-678.